Jonathan Allan, General Counsel & Corp Sec: Stoke Therapeutics STOK Sell · Filed 10/02

Trade details

Type: Insider sale
Amount: $16,508.91
Shares · price: 627 sh · $26.33 a share
Held after: 20,598 sh
Stock: Stoke Therapeutics STOK
Person: Jonathan AllanGeneral Counsel & Corp Sec
Trade date: 26/10/02
Filed: 26/10/02
Days to filing: 0 days

Sold 3.0% of holdings

Share of holding sold: 3.0%

Stoke Therapeutics trades, last 26 weeks

What else happened in Stoke Therapeutics around then

Filed or reported within 30 days of the trade day · 09/02~11/01

Jonathan Allan's recent trades

Jonathan AllanGeneral Counsel & Corp Sec
Planned sale10b5-1 planStoke Therapeutics
Planned sale10b5-1 plan
Stoke Therapeutics
STOK
$16.3K
627 sh
$16.3K
Filed 10/02
Traded 10/02
Jonathan AllanGeneral Counsel & Corp Sec
Sell10b5-1 planStoke Therapeutics
Sell10b5-1 plan
Stoke Therapeutics
STOK
$43.6K
1,457 sh
$43.6K
Filed 06/18
Traded 06/16
Jonathan AllanGeneral Counsel & Corp Sec
Planned sale10b5-1 planStoke Therapeutics
Planned sale10b5-1 plan
Stoke Therapeutics
STOK
$43.7K
1,457 sh
$43.7K
Filed 06/16
Traded 06/16
Jonathan AllanGeneral Counsel & Corp Sec
Sell10b5-1 planStoke Therapeutics
Sell10b5-1 plan
Stoke Therapeutics
STOK
$292.4K
8,692 sh
$292.4K
Filed 03/24
Traded 03/20
Jonathan AllanGeneral Counsel & Corp Sec
Sell10b5-1 planStoke Therapeutics
Sell10b5-1 plan
Stoke Therapeutics
STOK
$20.7K
601 sh
$20.7K
Filed 03/24
Traded 03/20